Vertex Pharmaceuticals Board of Directors

FDA, Vertex Pharmaceuticals

Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).

Business Insider · 1d

Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to

MarketWatch · 1d

Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.

Vertex Pharmaceuticals announces FDA approval of Journavx

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration has approved JOURNAVX, an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor ...

The Business Journals11d

Vertex Energy emerges from Chapter 11 bankruptcy with new CEO, board

Refined fuels company Vertex Energy has a new CEO and a new board of directors upon exiting Chapter 11 bankruptcy protection. Vertex Energy Inc., which filed for Chapter 11 bankruptcy ...

2don MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA, Vertex Pharmaceuticals

Trending now